The recent disruptions in global supply have highlighted the value of securing critical medications like Ivermectin. Dependence on overseas vendors exposes countries to considerable vulnerabilities, including shipping delays, expense fluctuations, and even geopolitical concerns. Transitioning towards domestic procurement of Ivermectin offers a mult